MedPath

Androgens for Poor Responders in In Vitro Fertilization

Phase 3
Completed
Conditions
Ovarian Response
Interventions
Registration Number
NCT00693108
Lead Sponsor
Hospital Clinic of Barcelona
Brief Summary

it has been shown that androgens in non human primates may favour follicular growth in the ovaries when animals are treated with gonadotropins which are the hormones used in patients receiving treatment with in vitro fertilization. Therefore, this study investigates the potential usefulness of testosterone treatment preceding gonadotropin administration in in vitro fertilization patients having a previous poor response to gonadotropins alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Patients receiving the second IVF treatment attempt having the first treatment cycle cancelled because of poor ovarian response to gonadotropins
Exclusion Criteria
  • Previous ovarian surgery
  • Clinical or laboratory profile suggesting premature ovarian failure

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1Transdermal testosteroneTransdermal testosterone treatment during the five days preceding gonadotropin therapy in IVF cycles
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital Clinic

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath